No abstract

No abstract

No abstract

Background: Some authors have challenged the benefit of breast cancer mammographic screening due to high prevalence of overdiagnosis and overtreatment. Purpose: To assess the anxiety and stress of women undergoing a microbiopsy following a false positive breast cancer screening and to evaluate whether this experience refrains them from continuing breast cancer screening. Methods: 296 patients underwent breast microbiopsy for positive breast cancer screening B1, B2 and B3 lesions in our Breast Center between 2011 and 2013. Patients undergoing microbiopsy for B4 and B5 lesions were excluded from the study. The patients were thereafter interviewed by our two psychologists by phone within a time range of 6 to 18 months following the biopsy. Results: 201 women answered the questionnaire (68% response). 5.5% had a breast lesion at risk and 75% had a benign lesion. Half of the women rated their anxiety as high (7-8 on a scalebetween 0 – 10) and 15% as very high (9-10/10) before the biopsy. While waiting for the result, 42% rated their anxiety as high (7-8/10) and nearly a third as very high (9-10/10). But 80% accepted to continue breast cancer screening and 90% would accept to undergo again a microbiopsy if necessary. Conclusion: microbiopsy provides high stress in most patients undergoing it. Nevertheless, 90% of those who had a false positive results accept it and are willing to undergo a biopsy again if necessary. Citation Format: Birgit Carly, Mireille Aimont, Nicolas Beauloye, Fabienne Liebens. Perception of women after undergoing microbiopsy following a positive breast cander screening [abstract]. In: Proceedings of the Thirty-Seventh Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2014 Dec 9-13; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2015;75(9 Suppl):Abstract nr P2-12-15.

De plus en plus, le cancer est considéré comme une maladie chronique avec ou sans phase aiguë, avec ou sans rémission. Une chronicité qui dans le discours des soignants, ou celui des patients, risque de banaliser, voire de faire taire l’expression de l’impact psychique du cancer et de ses traitements. Or, la chronicité ne peut que faire écran de la souffrance qui ne consiste pas seulement dans le poids de la maladie et de ses traitements, mais aussi dans le rythme qu’ils impriment à l’existence. Chronicité qui est ellemême source de souffrance. Cet article établit le parallèle entre le mythe de Sisyphe écrit par Camus et la condition, voire l’identité, du patient chronique atteint d’un cancer. Si l’ouvrage de Sisyphe n’est jamais terminé, celui du patient connaît une fin.